Trials / Unknown
UnknownNCT04156841
Sentinel Lymph Node Biopsy in Early Breast Cancer: a Real-world Multicenter Cross-sectional Study (CABS001 Study)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 21,000 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Objective: To investigate the current clinical practice of sentinel lymph node biopsy (SLNB) in patients with early stage breast cancer in China. Methods: The data of early breast cancer patients who underwent SLNB in 40 Grade III Level A hospitals in China in 2018 will be collected. Different centers, tracer methods, molecular typing and neoadjuvant chemotherapy will be used as stratification factors to analyze the implementation rate, number of detections, positive rate of SLNB and the follow-up treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | mapping agent | according to different tracer methods, patients are divided into the implementation of a single mapping agent and implementation of combination of blue dye and radiotracer agent. |
| PROCEDURE | neoadjuvant chemotherapy | Patients were divided into two groups based on whether they were receiving neoadjuvant chemotherapy. |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2020-12-31
- Completion
- 2021-12-31
- First posted
- 2019-11-08
- Last updated
- 2019-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04156841. Inclusion in this directory is not an endorsement.